BioPharma Drug Discovery

Full-Life Technologies Secures $571.5M Licensing Deal with SK Biopharmaceuticals for Anti-Cancer Radiopharmaceutical FL-091

Full-Life Technologies seals $571.5 million agreement with SK Biopharmaceuticals to license and further develop Full-Life's 'FL-091' ra...

 September 19, 2024 | News

Singapore Becomes First Southeast Asian Market to Launch BESREMi®️, Setting a New Standard for Rare Disease Care

PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator specializing in haematology and oncology, proudly announces the launch of BES...

 September 17, 2024 | News

Senhwa Biosciences' Silmitasertib Receives Rare Pediatric Disease Designation from US FDA for Neuroblastoma

Senhwa Biosciences, Inc. (TPEx: 6492), a new drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious d...

 September 13, 2024 | News

NextPoint Therapeutics Introduces NPX372, a Novel T Cell Engager Targeting B7-H7 Axis in Solid Tumors

NextPoint Therapeutics, a clinical-stage biotechnology company developing a new class of precision immuno-oncology and tumor-directed therapeutics targetin...

 September 09, 2024 | News

HKBU’s Centre for Chinese Herbal Medicine Drug Development Receives Approval for Clinical Trial of Novel Ulcerative Colitis Drug

Centre for Chinese Herbal Medicine Drug Development (CDD) at Hong Kong Baptist University (HKBU) has achieved a significant milestone in dev...

 September 05, 2024 | News

Skyline Therapeutics Secures FDA Orphan Drug Designation for Gene Therapy SKG1108 to Treat Retinitis Pigmentosa

Skyline Therapeutics, an innovation-driven gene therapy company committed to developing unique and novel solutions for rare and severe diseases, announced ...

 September 04, 2024 | News

Jacobio Pharma Grants China Rights for KRAS G12C and SHP2 Inhibitors to Shanghai Allist in Landmark Deal

 Jacobio Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable targets, today announced that it has granted the China ...

 September 02, 2024 | News

European Commission Approves BRAFTOVI® + MEKTOVI® Combo for BRAFV600E-Mutated Advanced NSCLC

European approval is based on results from the Phase II PHAROS trial, which showed a meaningful clinical benefit to BRAFV600E mutated advanced ...

 September 02, 2024 | News

Hyundai Bioscience Advances Xafty® as Sole Oral COVID-19 Treatment for High-Risk Patients Ineligible for Paxlovid®

"Xafty® can be the only oral COVID-19 treatment that can be prescribed to high-risk group patients who cannot take Paxlovid®" "While maintaining...

 August 29, 2024 | News

Zuellig Pharma Secures Exclusive Distribution Agreement with Regeneron to Launch Libtayo® in South Korea and Taiwan

Zuellig Pharma, a leading healthcare solutions company in Asia, has announced an exclusive distribution agreement with Regeneron Ireland DAC, a wholly owne...

 August 28, 2024 | News

Telix Pharmaceuticals Submits NDA to FDA for Innovative Brain Cancer Imaging Agent Pixclara®

Telix Pharmaceuticals announces it has submitted a New Drug Application (NDA) to the United States (U.S.) Food and Drug Administration (FDA) for ...

 August 28, 2024 | News

ArkBio CEO Presents Promising IPF Drug AK3280 at 8th Annual IPF Summit in Boston

Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio"), a privately held, clinical-stage biopharmaceutical company today announced that Dr. Jim Wu, Chief...

 August 27, 2024 | News

Dr. Reddy’s, Aurigene, and Kainomyx Partner to Develop Affordable Anti-Malarial Drug for Global Public Health

Malaria is a life-threatening public health issue, particularly in low- and middle-income countries. There is a need for an effective, affordable, ...

 August 21, 2024 | News

Kelun-Biotech's NDA for Sacituzumab Tirumotecan Accepted by China's NMPA Following Positive Lung Cancer Study Results

New drug application (NDA) for the core product sacituzumab tirumotecan (sac-TMT, formerly SKB264/MK-2870) based on the positive results from the pivotal O...

 August 21, 2024 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close